Showing results (2381-2390 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 24, 2000
Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinomaM Uehara, K Sano, Z L Wang, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2000
CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectorsL F Erdile, D Smith
Cancer Immunology, Immunotherapy : CII|December 29, 2000
The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccinesP Arlen, K Y Tsang, J L Marshall, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2000
Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor immune responseM D Jyothi, A Khar
Cancer Immunology, Immunotherapy : CII|July 19, 2001
Role of adhesion molecules in recruitment of Vdelta1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patientsM L Thomas, R A Badwe, R K Deshpande, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2000
Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptidesB W Anderson, A P Kudelka, T Honda, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2000
Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomasK Warzocha, P Ribeiro, N Renard, et al.
Cancer Immunology, Immunotherapy : CII|September 26, 2001
Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosisR M Prins, M R Graf, R E Merchant
Cancer Immunology, Immunotherapy : CII|May 24, 2000
Synergistic effect of interleukin-15 and interleukin-12 on antitumor activity in a murine malignant pleurisy modelK Kimura, H Nishimura, T Matsuzaki, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2000
Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expressionD O McCarthy, N Glowacki, K Schell, et al.
Pageof 652